Diabetes Care 25:458-463, 2002
© 2002 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research Original Article |
Health-Related Quality of Life and Treatment Satisfaction in Dutch Patients With Type 2 Diabetes
W. Ken Redekop, PHD1,
Marc A. Koopmanschap, PHD1,
Ronald P. Stolk, MD, PHD2,
Guy E.H.M. Rutten, MD, PHD2,
Bruce H.R. Wolffenbuttel, MD, PHD3 and
Louis W. Niessen, MD1
1 Institute for Medical Technology Assessment (iMTA), Erasmus University, Rotterdam, the Netherlands
2 Julius Center for General Practice and Patient-Oriented Research, University Medical Center, Utrecht, the Netherlands
3 Academic Center Maastricht, Maastricht, the Netherlands
OBJECTIVE To estimate the health-related quality of life (HRQOL) and treatment satisfaction for patients with type 2 diabetes in the Netherlands and to examine which patient characteristics are associated with quality of life and treatment satisfaction.
RESEARCH DESIGN AND METHODSFor a sample of 1,348 type 2 diabetes patients, recruited by 29 general practitioners, we collected data regarding HRQOL. This study was performed as part of a larger European study (Cost of Diabetes in Europe - Type 2 [CODE-2]). We used a generic instrument (Euroqol 5D) to measure HRQOL. Treatment satisfaction was assessed using the Diabetes Treatment Satisfaction Questionnaire.
RESULTSPatients without complications had an HRQOL (0.74) only slightly lower than similarly aged persons in the general population. Insulin therapy, obesity, and complications were associated with a lower HRQOL, independent of age and sex. Although higher fasting blood glucose and HbA1c levels were negatively associated with HRQOL, these factors were not significant after adjustment for other factors using multivariate analysis. Overall treatment satisfaction was very high. Younger patients, patients using insulin, and patients with higher HbA1c levels were less satisfied with the treatment than other patients.
CONCLUSIONSObesity and the presence of complications are important determinants of HRQOL in patients with type 2 diabetes.
Abbreviations: CODE-2, Cost of Diabetes in Europe - Type 2 DTSQ, Diabetes Treatment Satisfaction Questionnaire HRQOL, health-related quality of life VAS, visual analog scale

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. van Bruggen, K. J Goter, R. P Stolk, R. P Verhoeven, and G. E H M Rutten
Implementation of locally adapted guidelines on type 2 diabetes
Fam. Pract.,
August 21, 2008;
(2008)
cmn045v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Fisher, C. T. Thorpe, B. M. DeVellis, and R. F. DeVellis
Healthy Coping, Negative Emotions, and Diabetes Management: A Systematic Review and Appraisal
The Diabetes Educator,
November 1, 2007;
33(6):
1080 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Maddigan, D. H. Feeny, S. R. Majumdar, K. B. Farris, and J. A. Johnson
Understanding the Determinants of Health for People With Type 2 Diabetes
Am J Public Health,
September 1, 2006;
96(9):
1649 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Wexler
Low risk of depression in diabetes? Would that it were so.
Can. Med. Assoc. J.,
July 4, 2006;
175(1):
47 - 47.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Hayes, L. Bowman, P. O. Monahan, D. G. Marrero, and C. A. McHorney
Understanding diabetes medications from the perspective of patients with type 2 diabetes: prerequisite to medication concordance.
The Diabetes Educator,
May 1, 2006;
32(3):
404 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Chyun, G. D. Melkus, D. M. Katten, W. J. Price, J. A. Davey, N. Grey, G. Heller, and F. J. Th. Wackers
The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes.
Biol Res Nurs,
April 1, 2006;
7(4):
279 - 288.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Huang, M. Shook, L. Jin, M. H. Chin, and D. O. Meltzer
The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Diabetes Care,
February 1, 2006;
29(2):
259 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Maddigan, S. R. Majumdar, L. M. Guirguis, R. Z. Lewanczuk, T. K. Lee, E. L. Toth, and J. A. Johnson
Improvements in Patient-Reported Outcomes Associated With an Intervention to Enhance Quality of Care for Rural Patients With Type 2 Diabetes: Results of a controlled trial
Diabetes Care,
June 1, 2004;
27(6):
1306 - 1312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Dent, D Armstrong, B Delaney, P Moayyedi, N J Talley, and N Vakil
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs
Gut,
May 1, 2004;
53(suppl_4):
iv1 - iv24.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Coffey, M. Brandle, H. Zhou, D. Marriott, R. Burke, B. P. Tabaei, M. M. Engelgau, R. M. Kaplan, and W. H. Herman
Valuing Health-Related Quality of Life in Diabetes
Diabetes Care,
December 1, 2002;
25(12):
2238 - 2243.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|